Yu‐Ting Tseng
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 8
-
- Gold and Silver Nanoparticles Synthesis and Applications 8
- Co-authors
- Yi‐Ching Lo (21 shared papers)Chih‐Ching Huang (12 shared papers)Huan‐Tsung Chang (11 shared papers)Chih‐Hung Chou (1 shared paper)Hsi‐Yuan Huang (1 shared paper)Ting-Yan Jian (1 shared paper)Hsien‐Da Huang (1 shared paper)Shu-Yi Ho (1 shared paper)
- Journals
- Nucleic Acids Research (4 papers)Phytomedicine (3 papers)British Journal of Pharmacology (3 papers)The Lancet (2 papers)Sensors and Actuators B Chemical (2 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Yu‐Ting Tseng
82 papers receiving 3.5k citations
Yu‐Ting Tseng's Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 589
- Infectious Diseases 364
- Molecular Biology 851
- Complementary and alternative medicine 126
- Biomaterials 109
Countries citing papers authored by Yu‐Ting Tseng
This map shows the geographic impact of Yu‐Ting Tseng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Ting Tseng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Ting Tseng more than expected).
Fields of papers citing papers by Yu‐Ting Tseng
This network shows the impact of papers produced by Yu‐Ting Tseng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Ting Tseng. The network helps show where Yu‐Ting Tseng may publish in the future.
Co-authors
The 25 scholars most cited alongside Yu‐Ting Tseng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions Hit paper breakdown → | 2013 | 949 |
| 2 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials Hit paper breakdown → | 2018 | 313 |
| 3 | 2015 | 218 | |
| 4 | 2021 | 134 | |
| 5 | 2013 | 125 | |
| 6 | 2015 | 118 | |
| 7 | 2016 | 100 | |
| 8 | 2014 | 86 | |
| 9 | 2011 | 84 | |
| 10 | 2017 | 77 | |
| 11 | 2017 | 72 | |
| 12 | 2015 | 70 | |
| 13 | 2016 | 63 | |
| 14 | 2016 | 58 | |
| 15 | 2020 | 56 | |
| 16 | 2012 | 48 | |
| 17 | 2007 | 46 | |
| 18 | 2014 | 45 | |
| 19 | 2018 | 45 | |
| 20 | 2013 | 42 |
About Yu‐Ting Tseng
Yu‐Ting Tseng is a scholar working on Infectious Diseases, Electronic, Optical and Magnetic Materials, Psychiatry and Mental health, Clinical Biochemistry and Genetics, having authored 89 papers that have together received 3.6k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Gold and Silver Nanoparticles Synthesis and Applications (8 papers), Nanocluster Synthesis and Applications (5 papers), Neurogenetic and Muscular Disorders Research (4 papers), Advanced Glycation End Products research (4 papers), Schizophrenia research and treatment (4 papers), Bioinformatics and Genomic Networks (3 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). The work is most often cited by research in Cancer Research (589 citations), Infectious Diseases (364 citations), Molecular Biology (851 citations), Complementary and alternative medicine (126 citations) and Biomaterials (109 citations). Yu‐Ting Tseng has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Yi‐Ching Lo, Chih‐Ching Huang, Huan‐Tsung Chang, Chih‐Hung Chou, Hsi‐Yuan Huang, Ting-Yan Jian, Hsien‐Da Huang, Shu-Yi Ho, Ching-Min Lin and Sheng‐Da Hsu. Their work appears in journals such as Nucleic Acids Research, Phytomedicine, British Journal of Pharmacology, The Lancet and Sensors and Actuators B Chemical.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.